Biomarkers of extracellular matrix formation are associated with acute-on-chronic liver failure

Background & Aims: Acute-on-chronic liver failure (ACLF) is characterised by organ failure(s), high short-term mortality, and, pathophysiologically, deranged inflammatory responses. The extracellular matrix (ECM) is critically involved in regulating the inflammatory response. This study aime...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Annarein J.C. Kerbert, Saurabh Gupta, Eman Alabsawy, Iwona Dobler, Ida Lønsmann, Andrew Hall, Signe Holm Nielsen, Mette J. Nielsen, Henning Gronbaek, Àlex Amoros, Dave Yeung, Jane Macnaughtan, Rajeshwar P. Mookerjee, Stewart Macdonald, Fausto Andreola, Richard Moreau, Vicente Arroyo, Paolo Angeli, Diana J. Leeming, William Treem, Morten A. Karsdal, Rajiv Jalan
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/60899aef3e0647849024975785540415
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:60899aef3e0647849024975785540415
record_format dspace
spelling oai:doaj.org-article:60899aef3e06478490249757855404152021-11-20T05:11:35ZBiomarkers of extracellular matrix formation are associated with acute-on-chronic liver failure2589-555910.1016/j.jhepr.2021.100355https://doaj.org/article/60899aef3e06478490249757855404152021-12-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2589555921001312https://doaj.org/toc/2589-5559Background &amp; Aims: Acute-on-chronic liver failure (ACLF) is characterised by organ failure(s), high short-term mortality, and, pathophysiologically, deranged inflammatory responses. The extracellular matrix (ECM) is critically involved in regulating the inflammatory response. This study aimed to determine alterations in biomarkers of ECM turnover in ACLF and their association with inflammation, organ failures, and mortality. Methods: We studied 283 patients with cirrhosis admitted for acute decompensation (AD) with or without ACLF, 64 patients with stable cirrhosis, and 30 healthy controls. A validation cohort (25 ACLF, 9 healthy controls) was included. Plasma PRO-C3, PRO-C4, PRO-C5, PRO-C6, and PRO-C8 (i.e. collagen type III–VI and VIII formation) and C4M and C6M (i.e. collagen type IV and VI degradation) were measured. Immunohistochemistry of PRO-C6 was performed on liver biopsies (AD [n = 7], ACLF [n = 5]). A competing-risk regression analysis was performed to explore the prognostic value of biomarkers of ECM turnover with 28- and 90-day mortality. Results: PRO-C3 and PRO-C6 were increased in ACLF compared to AD (p = 0.089 and p <0.001, respectively), whereas collagen degradation markers C4M and C6M were similar. Both PRO-C3 and PRO-C6 were strongly associated with liver function and inflammatory markers. Only PRO-C6 was associated with extrahepatic organ failures and 28- and 90-day mortality (hazard ratio [HR; on log-scale] 6.168, 95% CI 2.366–16.080, p <0.001, and 3.495, 95% CI 1.509–8.093, p = 0.003, respectively). These findings were consistent in the validation cohort. High PRO-C6 expression was observed in liver biopsies of patients with ACLF. Conclusions: This study shows, for the first time, evidence of severe net interstitial collagen deposition in ACLF and makes the novel observation of the association between PRO-C6 and (extrahepatic) organ failures and mortality. Further studies are needed to define the pathogenic significance of these observations. Lay summary: This study describes a disrupted turnover of collagen type III and VI in Acute-on-chronic liver failure (ACLF). Plasma biomarkers of these collagens (PRO-C3 and PRO-C6) are associated with the severity of liver dysfunction and inflammation. PRO-C6, also known as the hormone endotrophin, has also been found to be associated with multi-organ failure and prognosis in acute decompensation and ACLF.Annarein J.C. KerbertSaurabh GuptaEman AlabsawyIwona DoblerIda LønsmannAndrew HallSigne Holm NielsenMette J. NielsenHenning GronbaekÀlex AmorosDave YeungJane MacnaughtanRajeshwar P. MookerjeeStewart MacdonaldFausto AndreolaRichard MoreauVicente ArroyoPaolo AngeliDiana J. LeemingWilliam TreemMorten A. KarsdalRajiv JalanElsevierarticleLiver cirrhosisMulti-organ failureCollagenPrognosisDiseases of the digestive system. GastroenterologyRC799-869ENJHEP Reports, Vol 3, Iss 6, Pp 100355- (2021)
institution DOAJ
collection DOAJ
language EN
topic Liver cirrhosis
Multi-organ failure
Collagen
Prognosis
Diseases of the digestive system. Gastroenterology
RC799-869
spellingShingle Liver cirrhosis
Multi-organ failure
Collagen
Prognosis
Diseases of the digestive system. Gastroenterology
RC799-869
Annarein J.C. Kerbert
Saurabh Gupta
Eman Alabsawy
Iwona Dobler
Ida Lønsmann
Andrew Hall
Signe Holm Nielsen
Mette J. Nielsen
Henning Gronbaek
Àlex Amoros
Dave Yeung
Jane Macnaughtan
Rajeshwar P. Mookerjee
Stewart Macdonald
Fausto Andreola
Richard Moreau
Vicente Arroyo
Paolo Angeli
Diana J. Leeming
William Treem
Morten A. Karsdal
Rajiv Jalan
Biomarkers of extracellular matrix formation are associated with acute-on-chronic liver failure
description Background &amp; Aims: Acute-on-chronic liver failure (ACLF) is characterised by organ failure(s), high short-term mortality, and, pathophysiologically, deranged inflammatory responses. The extracellular matrix (ECM) is critically involved in regulating the inflammatory response. This study aimed to determine alterations in biomarkers of ECM turnover in ACLF and their association with inflammation, organ failures, and mortality. Methods: We studied 283 patients with cirrhosis admitted for acute decompensation (AD) with or without ACLF, 64 patients with stable cirrhosis, and 30 healthy controls. A validation cohort (25 ACLF, 9 healthy controls) was included. Plasma PRO-C3, PRO-C4, PRO-C5, PRO-C6, and PRO-C8 (i.e. collagen type III–VI and VIII formation) and C4M and C6M (i.e. collagen type IV and VI degradation) were measured. Immunohistochemistry of PRO-C6 was performed on liver biopsies (AD [n = 7], ACLF [n = 5]). A competing-risk regression analysis was performed to explore the prognostic value of biomarkers of ECM turnover with 28- and 90-day mortality. Results: PRO-C3 and PRO-C6 were increased in ACLF compared to AD (p = 0.089 and p <0.001, respectively), whereas collagen degradation markers C4M and C6M were similar. Both PRO-C3 and PRO-C6 were strongly associated with liver function and inflammatory markers. Only PRO-C6 was associated with extrahepatic organ failures and 28- and 90-day mortality (hazard ratio [HR; on log-scale] 6.168, 95% CI 2.366–16.080, p <0.001, and 3.495, 95% CI 1.509–8.093, p = 0.003, respectively). These findings were consistent in the validation cohort. High PRO-C6 expression was observed in liver biopsies of patients with ACLF. Conclusions: This study shows, for the first time, evidence of severe net interstitial collagen deposition in ACLF and makes the novel observation of the association between PRO-C6 and (extrahepatic) organ failures and mortality. Further studies are needed to define the pathogenic significance of these observations. Lay summary: This study describes a disrupted turnover of collagen type III and VI in Acute-on-chronic liver failure (ACLF). Plasma biomarkers of these collagens (PRO-C3 and PRO-C6) are associated with the severity of liver dysfunction and inflammation. PRO-C6, also known as the hormone endotrophin, has also been found to be associated with multi-organ failure and prognosis in acute decompensation and ACLF.
format article
author Annarein J.C. Kerbert
Saurabh Gupta
Eman Alabsawy
Iwona Dobler
Ida Lønsmann
Andrew Hall
Signe Holm Nielsen
Mette J. Nielsen
Henning Gronbaek
Àlex Amoros
Dave Yeung
Jane Macnaughtan
Rajeshwar P. Mookerjee
Stewart Macdonald
Fausto Andreola
Richard Moreau
Vicente Arroyo
Paolo Angeli
Diana J. Leeming
William Treem
Morten A. Karsdal
Rajiv Jalan
author_facet Annarein J.C. Kerbert
Saurabh Gupta
Eman Alabsawy
Iwona Dobler
Ida Lønsmann
Andrew Hall
Signe Holm Nielsen
Mette J. Nielsen
Henning Gronbaek
Àlex Amoros
Dave Yeung
Jane Macnaughtan
Rajeshwar P. Mookerjee
Stewart Macdonald
Fausto Andreola
Richard Moreau
Vicente Arroyo
Paolo Angeli
Diana J. Leeming
William Treem
Morten A. Karsdal
Rajiv Jalan
author_sort Annarein J.C. Kerbert
title Biomarkers of extracellular matrix formation are associated with acute-on-chronic liver failure
title_short Biomarkers of extracellular matrix formation are associated with acute-on-chronic liver failure
title_full Biomarkers of extracellular matrix formation are associated with acute-on-chronic liver failure
title_fullStr Biomarkers of extracellular matrix formation are associated with acute-on-chronic liver failure
title_full_unstemmed Biomarkers of extracellular matrix formation are associated with acute-on-chronic liver failure
title_sort biomarkers of extracellular matrix formation are associated with acute-on-chronic liver failure
publisher Elsevier
publishDate 2021
url https://doaj.org/article/60899aef3e0647849024975785540415
work_keys_str_mv AT annareinjckerbert biomarkersofextracellularmatrixformationareassociatedwithacuteonchronicliverfailure
AT saurabhgupta biomarkersofextracellularmatrixformationareassociatedwithacuteonchronicliverfailure
AT emanalabsawy biomarkersofextracellularmatrixformationareassociatedwithacuteonchronicliverfailure
AT iwonadobler biomarkersofextracellularmatrixformationareassociatedwithacuteonchronicliverfailure
AT idalønsmann biomarkersofextracellularmatrixformationareassociatedwithacuteonchronicliverfailure
AT andrewhall biomarkersofextracellularmatrixformationareassociatedwithacuteonchronicliverfailure
AT signeholmnielsen biomarkersofextracellularmatrixformationareassociatedwithacuteonchronicliverfailure
AT mettejnielsen biomarkersofextracellularmatrixformationareassociatedwithacuteonchronicliverfailure
AT henninggronbaek biomarkersofextracellularmatrixformationareassociatedwithacuteonchronicliverfailure
AT alexamoros biomarkersofextracellularmatrixformationareassociatedwithacuteonchronicliverfailure
AT daveyeung biomarkersofextracellularmatrixformationareassociatedwithacuteonchronicliverfailure
AT janemacnaughtan biomarkersofextracellularmatrixformationareassociatedwithacuteonchronicliverfailure
AT rajeshwarpmookerjee biomarkersofextracellularmatrixformationareassociatedwithacuteonchronicliverfailure
AT stewartmacdonald biomarkersofextracellularmatrixformationareassociatedwithacuteonchronicliverfailure
AT faustoandreola biomarkersofextracellularmatrixformationareassociatedwithacuteonchronicliverfailure
AT richardmoreau biomarkersofextracellularmatrixformationareassociatedwithacuteonchronicliverfailure
AT vicentearroyo biomarkersofextracellularmatrixformationareassociatedwithacuteonchronicliverfailure
AT paoloangeli biomarkersofextracellularmatrixformationareassociatedwithacuteonchronicliverfailure
AT dianajleeming biomarkersofextracellularmatrixformationareassociatedwithacuteonchronicliverfailure
AT williamtreem biomarkersofextracellularmatrixformationareassociatedwithacuteonchronicliverfailure
AT mortenakarsdal biomarkersofextracellularmatrixformationareassociatedwithacuteonchronicliverfailure
AT rajivjalan biomarkersofextracellularmatrixformationareassociatedwithacuteonchronicliverfailure
_version_ 1718419544225087488